Melanson SE - Search Results

1

The clinical impact of a false-positive urine cocaine screening result on a patient's pain management.

Kim JA, Ptolemy AS, Melanson SE, Janfaza DR, Ross EL. Kim JA, et al. Among authors: melanson se. Pain Med. 2015 Jun;16(6):1073-6. doi: 10.1111/pme.12265. Epub 2013 Oct 18. Pain Med. 2015. PMID: 24138673

2

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective.

Melanson SE, Kredlow MI, Jarolim P. Melanson SE, et al. Clin Chem Lab Med. 2009;47(8):971-6. doi: 10.1515/CCLM.2009.220. Clin Chem Lab Med. 2009. PMID: 19589103

3

Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys.

Melanson SE, Baskin L, Magnani B, Kwong TC, Dizon A, Wu AH. Melanson SE, et al. Arch Pathol Lab Med. 2010 May;134(5):735-9. doi: 10.5858/134.5.735. Arch Pathol Lab Med. 2010. PMID: 20441504 Free article.

4

A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance.

Snyder ML, Jarolim P, Melanson SE. Snyder ML, et al. Among authors: melanson se. Clin Chim Acta. 2011 May 12;412(11-12):946-51. doi: 10.1016/j.cca.2011.01.029. Epub 2011 Jan 31. Clin Chim Acta. 2011. PMID: 21281622

5

A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.

Melanson SE, Snyder ML, Jarolim P, Flood JG. Melanson SE, et al. J Anal Toxicol. 2012 Apr;36(3):201-6. doi: 10.1093/jat/bks003. J Anal Toxicol. 2012. PMID: 22417836

6

The utility of immunoassays for urine drug testing.

Melanson SE. Melanson SE. Clin Lab Med. 2012 Sep;32(3):429-47. doi: 10.1016/j.cll.2012.06.004. Epub 2012 Jun 22. Clin Lab Med. 2012. PMID: 22939301 Review.

7

Significant cost savings achieved by in-sourcing urine drug testing for monitoring medication compliance in pain management.

Melanson SE, Tanasijevic MJ, Snyder ML, Darragh A, Quade C, Jarolim P. Melanson SE, et al. Clin Chim Acta. 2013 Jun 25;422:10-4. doi: 10.1016/j.cca.2013.03.010. Epub 2013 Mar 29. Clin Chim Acta. 2013. PMID: 23545276

8

Optimizing urine drug testing for monitoring medication compliance in pain management.

Melanson SE, Ptolemy AS, Wasan AD. Melanson SE, et al. Pain Med. 2013 Dec;14(12):1813-20. doi: 10.1111/pme.12207. Epub 2013 Jul 30. Pain Med. 2013. PMID: 23899241

9

Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.

Snyder ML, Darragh A, Flood JG, Jones J, Ropar K, Jarolim P, Melanson SE. Snyder ML, et al. Among authors: melanson se. J Anal Toxicol. 2014 Jul-Aug;38(6):375-9. doi: 10.1093/jat/bku045. Epub 2014 May 6. J Anal Toxicol. 2014. PMID: 24802159

10

KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.

Darragh A, Snyder ML, Ptolemy AS, Melanson S. Darragh A, et al. Pain Physician. 2014 Jul-Aug;17(4):359-66. Pain Physician. 2014. PMID: 25054395 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters